Your browser doesn't support javascript.
loading
Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma.
Park, Cheol Keun; Heo, Jayoon; Ham, Won Sik; Choi, Young-Deuk; Shin, Sang Joon; Cho, Nam Hoon.
Afiliación
  • Park CK; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
  • Heo J; Division of Hemato-Oncology, National Health Insurance Service (NHIS) Ilsan Hospital, Goyang, Korea.
  • Ham WS; Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
  • Choi YD; Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea.
  • Shin SJ; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Cho NH; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
Cancer Res Treat ; 53(4): 1174-1183, 2021 Oct.
Article en En | MEDLINE | ID: mdl-33735560

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Biomarcadores de Tumor / Proteínas de Transporte de Catión / Complejos de Ubiquitina-Proteína Ligasa / Proteínas F-Box / Neoplasias Renales / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Treat Año: 2021 Tipo del documento: Article Pais de publicación:

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Biomarcadores de Tumor / Proteínas de Transporte de Catión / Complejos de Ubiquitina-Proteína Ligasa / Proteínas F-Box / Neoplasias Renales / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Res Treat Año: 2021 Tipo del documento: Article Pais de publicación: